StemCells Profile

11.52
USD 0.00  0.00%
0%
0%

StemCells Summary

StemCells (STEM) is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 74 people. The company currently falls under '' category with current market capitalization of 0. StemCells has 16.26 M outstanding shares of which 1.48 M shares are at this time shorted by private and institutional investors with about 0.0 trading days to cover. STEMCELLS INC currently holds about 2.08 M in cash with (31.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Check StemCells Probability Of Bankruptcy

Ownership Allocation (%)

Key Fundamentals

StemCells Against Markets

Similar Equity Warning - STEM

StemCells was forked
  The entity StemCells with a symbol STEM was recently forked. You can potentially use Microbot Medical with a symbol MBOT from now on.

Current Ratings

StemCells 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
50 
Equity ratings for StemCells are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cellbased therapeutics and related technologies. more
NameStemCells
CEOMartin McGlynnView All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressNewark, CA
ExchangeNasdaq Capital Markets
New SymbolMBOT
BenchmarkDOW
Websitewww.stemcellsinc.com
Phone510 456 4000
CurrencyUSD - US Dollar

StemCells Corporate Directors

Alan Trounson Director
Irving Weissman Director
Scott Greer Independent Director
Also please take a look at World Market Map. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.